[go: up one dir, main page]

AR229875A1 - Procedimiento para la preparacion de derivados de 4-sulfanoil fenil-3-sustituido-2-fenilimino-4-tiazolina,intermediarios para su uso exclusivo en el procedimiento y procedimiento para obtener preparados farmaceuticos - Google Patents

Procedimiento para la preparacion de derivados de 4-sulfanoil fenil-3-sustituido-2-fenilimino-4-tiazolina,intermediarios para su uso exclusivo en el procedimiento y procedimiento para obtener preparados farmaceuticos

Info

Publication number
AR229875A1
AR229875A1 AR281607A AR28160780A AR229875A1 AR 229875 A1 AR229875 A1 AR 229875A1 AR 281607 A AR281607 A AR 281607A AR 28160780 A AR28160780 A AR 28160780A AR 229875 A1 AR229875 A1 AR 229875A1
Authority
AR
Argentina
Prior art keywords
procedure
sulfanoil
penylimino
fenil
thiazoline
Prior art date
Application number
AR281607A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of AR229875A1 publication Critical patent/AR229875A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/66Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to halogen atoms or to nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30Isothioureas
    • C07C335/36Isothioureas having sulfur atoms of isothiourea groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/42Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AR281607A 1979-07-03 1980-07-01 Procedimiento para la preparacion de derivados de 4-sulfanoil fenil-3-sustituido-2-fenilimino-4-tiazolina,intermediarios para su uso exclusivo en el procedimiento y procedimiento para obtener preparados farmaceuticos AR229875A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792926771 DE2926771A1 (de) 1979-07-03 1979-07-03 Thiazolidinderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
AR229875A1 true AR229875A1 (es) 1983-12-30

Family

ID=6074772

Family Applications (3)

Application Number Title Priority Date Filing Date
AR281607A AR229875A1 (es) 1979-07-03 1980-07-01 Procedimiento para la preparacion de derivados de 4-sulfanoil fenil-3-sustituido-2-fenilimino-4-tiazolina,intermediarios para su uso exclusivo en el procedimiento y procedimiento para obtener preparados farmaceuticos
AR286305A AR226119A1 (es) 1979-07-03 1981-07-31 Procedimiento para preparar derivados de 4-sulfamoilfenil-3-sustituido-2-fenil-imino-4-tiazolina
AR286306A AR229876A1 (es) 1979-07-03 1981-07-31 Procedimiento para la preparacion de dos de 4-sulfa-moilfenil-3-sustituido-2-fenil-imino-4-tiazolina y procedimiento para obtener preparados farmaceuticos en base a dichos derivados

Family Applications After (2)

Application Number Title Priority Date Filing Date
AR286305A AR226119A1 (es) 1979-07-03 1981-07-31 Procedimiento para preparar derivados de 4-sulfamoilfenil-3-sustituido-2-fenil-imino-4-tiazolina
AR286306A AR229876A1 (es) 1979-07-03 1981-07-31 Procedimiento para la preparacion de dos de 4-sulfa-moilfenil-3-sustituido-2-fenil-imino-4-tiazolina y procedimiento para obtener preparados farmaceuticos en base a dichos derivados

Country Status (16)

Country Link
US (1) US4346088A (es)
EP (1) EP0023964B1 (es)
JP (1) JPS5610180A (es)
AR (3) AR229875A1 (es)
AT (1) ATE2524T1 (es)
AU (1) AU533589B2 (es)
CA (1) CA1156240A (es)
DE (2) DE2926771A1 (es)
DK (1) DK286580A (es)
EG (1) EG14763A (es)
ES (5) ES492874A0 (es)
FI (1) FI802094A7 (es)
HU (1) HU182164B (es)
IL (1) IL60468A (es)
NO (2) NO154132B (es)
ZA (1) ZA803979B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3049460A1 (de) * 1980-12-30 1982-07-29 Hoechst Ag, 6000 Frankfurt "thiazolinderivate, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
HU195492B (en) * 1984-07-27 1988-05-30 Boehringer Biochemia Srl Process for producing 2-substituted thiazolidine derivatives with antitussive and mucus regulating action and pharmaceuticals comprising these compounds as active ingredient
US5866595A (en) * 1991-09-26 1999-02-02 The Regents Of The University Of California Calcium antagonists for treatment of vascular restenosis
AU3201095A (en) * 1994-07-27 1996-02-22 G.D. Searle & Co. Substituted thiazoles for the treatment of inflammation
US6353006B1 (en) 1999-01-14 2002-03-05 Bayer Corporation Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
KR20010089831A (ko) * 1999-01-14 2001-10-08 조지 제이. 리코스 프로게스테론 수용체 결합제로 사용되는 치환된2-아릴이미노 헤테로싸이클 및 이를 포함하는 조성물
FR2796643B1 (fr) * 1999-07-22 2005-04-29 Sod Conseils Rech Applic Derives de 2-arylimino-2, 3-dihydrothiazoles, leurs procedes de preparation et leur utilisation therapeutique
FR2819508B1 (fr) * 2001-01-12 2005-01-21 Sod Conseils Rech Applic Derives de 2-arylimino-2, 3-dihydorthiazoles, leurs procedes de preparation et leur utilisation therapeutiques
EP1219612B1 (en) 1999-09-14 2008-04-23 Shionogi & Co., Ltd. 2-imino-1,3-thiazine derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2436263C2 (de) * 1974-07-27 1983-02-17 Hoechst Ag, 6000 Frankfurt Thiazolidinderivate und Verfahren zu ihrer Herstellung
DE2533821A1 (de) * 1975-07-29 1977-02-17 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
DE2546165A1 (de) * 1975-10-15 1977-04-28 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
SE7700436L (sv) * 1976-01-17 1977-07-18 Hoechst Ag Tiazolidinderivat och forfarande for deras framstellning

Also Published As

Publication number Publication date
DE2926771A1 (de) 1981-01-15
JPS5610180A (en) 1981-02-02
ES8103066A1 (es) 1981-02-16
NO801995L (no) 1981-01-05
ES8103068A1 (es) 1981-02-16
FI802094A7 (fi) 1981-01-01
ATE2524T1 (de) 1983-03-15
HU182164B (en) 1983-12-28
NO844120L (no) 1981-01-05
ES492872A0 (es) 1981-02-16
ES8103069A1 (es) 1981-02-16
AU533589B2 (en) 1983-12-01
ES492873A0 (es) 1981-02-16
AR229876A1 (es) 1983-12-30
US4346088A (en) 1982-08-24
EG14763A (en) 1986-09-30
DK286580A (da) 1981-01-04
ES8103067A1 (es) 1981-02-16
DE3062017D1 (en) 1983-03-24
ES492847A0 (es) 1981-02-16
IL60468A (en) 1984-11-30
AR226119A1 (es) 1982-05-31
ES492874A0 (es) 1981-02-16
EP0023964B1 (de) 1983-02-16
NO154132B (no) 1986-04-14
IL60468A0 (en) 1980-09-16
CA1156240A (en) 1983-11-01
ES8103065A1 (es) 1981-02-16
ZA803979B (en) 1981-06-24
EP0023964A1 (de) 1981-02-18
AU6003780A (en) 1981-01-15
ES492871A0 (es) 1981-02-16

Similar Documents

Publication Publication Date Title
AR224357A1 (es) Procedimiento para la preparacion de derivados de indanilo y tetrahidronaftilo y compuestos para su uso exclusivo en dicho procedimiento
IT8049108A0 (it) Nuovi eteri per uso farmaceutico eprocedimento per la loro preparazione
AR231541A1 (es) Procedimiento para preparar derivados de 3-amino-5-piridinil-2 1 h-piridinonas e intermediarios para uso en el mismo
ES489934A0 (es) Procedimiento para la preparacion de derivados de pipreridi-na
ES490536A0 (es) Procedimiento para la preparacion de derivados de la glici- namida
AR225744A1 (es) Un procedimiento para la preparacion de derivados n-substituidos de 3-feniluropilamina y derivados aplicados como intermediarios en dicho procedimiento
IT1217327B (it) Metodo per la preparazione di derivati gangliosidici e loro uso in preparazioni farmaceutiche
AR231987A1 (es) Procedimiento para preparar derivados farmaceuticos de pirrolo-2,1-c 1,4 tiazepin-1,5-diona y compuesto intermediario para uso exclusivo en el mismo
ES492289A0 (es) Procedimiento para la preparacion de derivados de nonapepti-dos y decapeptidos de hormona liberadora de hormona luteini-zante
ES492891A0 (es) Procedimiento para la preparacion de derivados triyodados deacido 5-amino- isoftalico
MX4324E (es) Procedimiento para la preparacion de derivados en aminoglicosido
AR221355A1 (es) Procedimiento para la preparacion de derivados de pirrolidinil y pirrolidinilmetil-benzamidas
AR230060A1 (es) Procedimiento para la preparacion de 3-aminosianonimias substituidas,aminoacetonitrilo substituido para su uso exclusivo en dicho procedimiento y procedimiento para su preparacion
IT7852041A0 (it) Peptidi e loro derivati per uso farmaceutico e procedimento per la preparazione delle formulazioni che licontengono
AR216080A1 (es) Derivados de 4-halo-dihidropirano,utiles como intermediarios en la preparacion de gamma-pironas,procedimiento para su preparacion y procedimiento para preparar una gamma-pirona partiendo de dichos intermediarios
IT1143047B (it) Composti diazepinici per uso farmaceutico e loro procedimento di preparazione
AR229875A1 (es) Procedimiento para la preparacion de derivados de 4-sulfanoil fenil-3-sustituido-2-fenilimino-4-tiazolina,intermediarios para su uso exclusivo en el procedimiento y procedimiento para obtener preparados farmaceuticos
AR220335A1 (es) Procedimiento para la preparacion de 4(2-hidroxi-3-(amino)-propoxi)-2-benzimidazolinonas y-tionas y compuestos para su exclusivo uso como intermediarios en dicho procedimiento
ES491142A0 (es) Procedimiento para la preparacion de derivados de fenileti- lamina
ES491154A0 (es) Procedimiento para la preparacion de derivados furanonicos
IT1123142B (it) Uso di glicerilfosforil derivati nella terapia di dislipemie ed epatiti,e composizioni farmaceutiche relative
IT1141135B (it) Derivati peptidici,procedimento per prepararli e relative composizioni farmaceutiche
MX6221E (es) Procedimiento para la preparacion de derivados de homoserina
IT1147741B (it) Derivati di idrossiammino eburnano e procedimento per la loro preparazione
IT1132403B (it) Derivati di alovincamone e procedimento per la loro preparazione